1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Tibotec BVBA: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Safety and Effectiveness Study of Telaprevir in Chronic, Genotype 1, Hepatitis C Patients That Failed Previous Standard Treatment Telaprevir, Peg-IFN-alfa-2a, Ribavirin - Hepatitis C, Chronic | Phase 3 | Completed | Tibotec BVBA | 663 | 2008-10-01 | 2014-01-22 |
Ribavirin (1) · peginterferon alfa-2a (1) · telaprevir (1)
Australia (1) · Austria (1) · Belgium (1) · Brazil (1) · Canada (1) · France (1) · Germany (1) · Israel (1) · Netherlands (1) · Poland (1) · Puerto Rico (1) · Spain (1) · Sweden (1) · Switzerland (1) · United Kingdom (1)